Development and Evaluation of Novel Anti-HER2 Theranostics Against HER2-Positive Breast Cancer
dc.contributor.advisor | Fonge, Humphrey | |
dc.contributor.committeeMember | Mousseau, Darrell | |
dc.contributor.committeeMember | Lukong, Erique | |
dc.contributor.committeeMember | Uppalapati, Maruti Chandra | |
dc.contributor.committeeMember | Dadachova, Kate | |
dc.contributor.committeeMember | Tolmachev, Vladimir | |
dc.contributor.committeeMember | Sakharkar, Meena | |
dc.creator | Pougoue Ketchemen, Jessica | |
dc.creator.orcid | 0000-0002-4574-8720 | |
dc.date.accessioned | 2024-09-20T20:04:31Z | |
dc.date.copyright | 2024 | |
dc.date.created | 2024-09 | |
dc.date.issued | 2024-09-20 | |
dc.date.submitted | September 2024 | |
dc.date.updated | 2024-09-20T20:04:32Z | |
dc.description.abstract | This item is under an embargo. Access to the abstract will not be permitted until 2025-09-20 | |
dc.format.mimetype | application/pdf | |
dc.identifier.uri | https://hdl.handle.net/10388/16064 | |
dc.language.iso | en | |
dc.subject | HER2-positive breast cancer | |
dc.subject | Theranostics | |
dc.subject | Actinium-225 | |
dc.subject | Copper-67 | |
dc.subject | Zirconium-89 | |
dc.subject | Trastuzumab-Resistance | |
dc.subject | Dosimetry | |
dc.subject | Toxicology | |
dc.subject | Radioimmunotherapy | |
dc.subject | Antibody-drug conjugates | |
dc.subject | PEGylation | |
dc.title | Development and Evaluation of Novel Anti-HER2 Theranostics Against HER2-Positive Breast Cancer | |
dc.type | Thesis | |
dc.type.material | text | |
local.embargo.lift | 2025-09-20 | |
local.embargo.terms | 2025-09-20 | |
thesis.degree.department | Medicine | |
thesis.degree.discipline | Health Sciences | |
thesis.degree.grantor | University of Saskatchewan | |
thesis.degree.level | Doctoral | |
thesis.degree.name | Doctor of Philosophy (Ph.D.) |
Files
License bundle
1 - 1 of 1